Importance Hepatocellular carcinoma (HCC) is the sixth most common malignancy and
fourth leading cause of cancer-related death worldwide. Recent advances in systemic and …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

Primary liver cancer is a challenging global health concern with an estimated more than a
million persons to be affected annually by the year 2025. The commonest type is …

Biomaterial-based implants hold great potential for postoperative cancer treatment due to
the enhanced drug dosage at the disease site and decreased systemic toxicity. However …

Liver cancer, specifically hepatocellular carcinoma (HCC), is the sixth most common cancer
and the third leading cause of cancer mortality worldwide. The development of effective …

Chitosan nanoparticles are well-known delivery systems widely used as polymeric carriers
in the field of nanomedicine. Chitosan is a carbohydrate of natural origin: it is a …

Background & Aims Assessment of recurrence risk after liver resection (LR) is critical in
hepatocellular carcinoma (HCC), particularly with the advent of effective adjuvant therapy …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. Our
previous reports showed that ginsenoside Rk3 provided excellent efficacy in alleviating the …

Liver cancer is a major global health problem whose incidence is on the rise. The
improvement in the understanding of the pathogenesis, early detection, diagnosis, staging …

Purpose To surmount the critical issues of indocyanine green (ICG), and thus achieving a
precise surgical navigation of primary liver cancer after long-term transcatheter arterial …